Regeneron Pharmaceuticals, Inc. (RGO)
Market Open
11 Aug, 06:08
€
695. 30
+12.1
+1.7711%
€
- Market Cap
24.52 P/E Ratio
0.22% Div Yield
30 Volume
42.79 Eps
€ 683.2
Previous Close Want to track RGO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | 9.13 | - |
| | | 10.71 | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
RGO Earnings Reports FAQ
What is the earnings per share (EPS) for RGO?
The current EPS is 42.79.
What is the company's earnings growth rate?
Regeneron Pharmaceuticals, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Regeneron Pharmaceuticals, Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Regeneron Pharmaceuticals, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for RGO at this time, as Regeneron Pharmaceuticals, Inc has no recent EPS data to calculate it.
